4 results
To investigate the long-term safety, tolerability and acceptability of Nasalfent in the treatment BTCP
The objective of the study is to evaluate the safety of the extended treatment with oral Cladribine and to determinate the effect on the QTc interval.other objectives:-explore the long term benefit (rate of disease progression as reflected by rate…
To determine the test-retest variability of Compass perimetry at the edges of glaucomatous scotomas and compare it with the Humphrey Field Analyzer.
The objective of this prospective, randomized study is to investigate the efficacy and safety of HSCT compared to the comparator group (alemtuzumab, cladribine or ocrelizumab) in patients with aggressive relapsing remitting MS. In Norway, the…